MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Clinical trials for MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION explained in plain language.
Never miss a new study
Get alerted when new MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION trials appear
Sign up with your email to follow new studies for MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart surgery sedative may shield your memory, large trial hopes
Disease control Recruiting nowThis phase 4 trial tests whether the sedative dexmedetomidine can prevent long-term thinking and memory problems after heart surgery. Researchers will give the drug to 2400 adults aged 60 and older during and after their operation, then track their brain function for a year. If s…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: PHASE4 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 23, 2026 12:09 UTC
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether taking just one blood thinner (single antiplatelet therapy) is safer and as effective as taking two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a balloon procedure to open blocked heart arteries. About 576…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Jun 17, 2026 12:10 UTC
-
New injection aims to smooth neck bands in phase 3 trial
Symptom relief Recruiting nowThis phase 3 study tests whether NT 201 (incobotulinumtoxinA, a type of botulinum toxin) can safely reduce the appearance of moderate to severe neck bands (platysma prominence) compared to a placebo. About 300 adults in Europe will receive injections and be followed for several w…
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: PHASE3 • Sponsor: Merz Aesthetics GmbH • Aim: Symptom relief
Last updated Jun 23, 2026 11:59 UTC
-
New hope for Treatment-Resistant depression: Fast-Acting drug trial launches
Symptom relief Recruiting nowThis study tests whether a new drug called HNK can quickly improve symptoms in people with major depression that hasn't responded to other treatments. About 50 adults aged 18 to 70 will receive four infusions of HNK and four of a placebo over several weeks, with their depression …
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Phase: PHASE2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
NIH launches study to decode depression and suicide risk
Knowledge-focused Recruiting nowThis study follows 500 adults receiving care for depression, bipolar disorder, or suicide risk. Researchers will use interviews, questionnaires, and optional tests like blood draws and brain scans to track how symptoms change over time. The goal is to find better ways to measure …
Matched conditions: MOLECULAR MECHANISMS OF PHARMACOLOGICAL ACTION
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:08 UTC